Chang, S.-F.; Chen, C.-N.; Lin, J.-C.; Wang, H.-E.; Mori, S.; Li, J.-J.; Yen, C.-K.; Hsu, C.-Y.; Fung, C.-P.; Chong, P.C.-S.;
et al. Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions. Cells 2020, 9, 1183.
https://doi.org/10.3390/cells9051183
AMA Style
Chang S-F, Chen C-N, Lin J-C, Wang H-E, Mori S, Li J-J, Yen C-K, Hsu C-Y, Fung C-P, Chong PC-S,
et al. Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions. Cells. 2020; 9(5):1183.
https://doi.org/10.3390/cells9051183
Chicago/Turabian Style
Chang, Shun-Fu, Cheng-Nan Chen, Jung-Chung Lin, Hsin-Ell Wang, Shigetarou Mori, Jia-Je Li, Chia-Kuang Yen, Ching-Yun Hsu, Chang-Phone Fung, Pele Choi-Sing Chong,
and et al. 2020. "Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions" Cells 9, no. 5: 1183.
https://doi.org/10.3390/cells9051183
APA Style
Chang, S.-F., Chen, C.-N., Lin, J.-C., Wang, H.-E., Mori, S., Li, J.-J., Yen, C.-K., Hsu, C.-Y., Fung, C.-P., Chong, P. C.-S., Leng, C.-H., Ding, Y.-J., Chang, F.-Y., & Siu, L. K.
(2020). Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions. Cells, 9(5), 1183.
https://doi.org/10.3390/cells9051183